Inventors:
Robert Redfield - Baltimore MD, US
Anthony Amoroso - Baltimore MD, US
Charles Davis - Laurel MD, US
Alonso Heredia - Washington DC, US
International Classification:
A61K 38/19, A61K 38/12, A61K 31/7076, A61K 39/395, A61K 31/551, A61K 31/522, A61K 31/355, A61K 31/19
US Classification:
424085100, 514045000, 514049000, 514220000, 514263320, 514291000, 514458000, 514557000, 514575000, 424145100
Abstract:
The present invention relates to compositions and methods for inducing increased levels and availability of β-chemokines by administering to a subject at least one G1 phase arresting compound, wherein the increased levels and availability of β-chemokines block chemokine/viral receptors thereby preventing or treating viral infections.